Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice
Behavioural Brain Research · 2024
DOI: 10.1016/j.bbr.2024.115019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavioural Brain Research, 2024. Verfasst von Belle Buzzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: buzzib@vcu.edu. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Reward, Nicotine, Mice, Inbred ICR. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, King Saud University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: buzzib@vcu.edu.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Förderung
- NIDA NIH HHS
- National Institutes of Health
- King Saud University
- National Institute on Drug Abuse
Zitieren
APA
Buzzi, B., AlSharari, S. D., Walentiny, D. M., & Damaj, M. I. (2024). Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2024.115019
Vancouver
Buzzi B, AlSharari SD, Walentiny DM, Damaj MI. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. Behavioural Brain Research. 2024. doi:10.1016/j.bbr.2024.115019
BibTeX
@article{Buzzi2024,
author = {Buzzi, Belle and AlSharari, Shakir D and Walentiny, David M and Damaj, M Imad},
title = {Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice},
journal = {Behavioural Brain Research},
year = {2024},
doi = {10.1016/j.bbr.2024.115019}
}
EUVIMED